Antiemetic properties of the antiepileptic drug levetiracetam.
Lee
Jong Woo
JW
Bromfield
Edward B
EB
Kesari
Santosh
S
D000367:Age Factors; D000927:Anticonvulsants / Q000627:therapeutic use*; D000932:Antiemetics / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001932:Brain Neoplasms / Q000188:drug therapy; D005909:Glioblastoma / Q000188:drug therapy; D006801:Humans; D000077287:Levetiracetam; D016015:Logistic Models; D009325:Nausea / Q000139:chemically induced / Q000517:prevention & control*; D010889:Piracetam / Q000031:analogs & derivatives* / Q000627:therapeutic use; D012189:Retrospective Studies; D014839:Vomiting / Q000139:chemically induced / Q000517:prevention & control*
D000927:Anticonvulsants; D000932:Antiemetics; D000970:Antineoplastic Agents; D000077287:Levetiracetam; D010889:Piracetam